Blank

Filgrastim r-methug-csf in clinical practice

Common Questions and Answers about Filgrastim r-methug-csf in clinical practice

neupogen

Avatar f tn In the absence of data, reduction in IFN dose and/or G-CSF dose for those who develop neutropenia while undergoing IFN-based therapy for HCV infection are often initiated in clinical practice, as suggested in treatment guidelines [6] and mandated in most clinical trials [15]. Reduction of IFN dose is well accepted to have a detrimental effect on the rate of sustained virological response [2].
Avatar m tn Hello and welcome! You have been diagnosed with Chiari as you can see. What you will find out is the size of the herniation is not as important as whether or not there is csf blockage and crowding of the brainstem. There are several reasons your tonsils maybe herniated: trauma, acquired, congenital. What I recommend is finding a Chiari specialist and taking your scans to see them. There is a list here in the forum of docs members have used and liked.
Avatar m tn I talked to my doc today and they said they were told by Barrow to be referred to Dr. Refai at Emory. Is this common practice? Also Refai's areas of clinical interest on the Emory website does not list chiari. Is there a way I can check if he even does that type of surgery or knows anything about it?
Avatar m tn Neulasta® (pegfilgrastim) or NEUPOGEN® (Filgrastim) may reduce your chance of getting an infection, but it does not prevent all infections. An infection can happen anytime your neutrophil counts are low. Look for signs of infection, such as fever, chills, rash, sore throat, diarrhea, or redness, swelling, or pain around a cut or sore. If you have any of these signs, contact your health care professional immediately. http://www.neulasta.com/starting-chemo-with-neulasta/about-neulasta-neupogen.
Avatar f tn Dear Suzi, welcome to the medhelp forum. Your MRI shows non-specific lesions or foci, less than a centimeter in size in the white matter, which need to be correlated with your clinical presentation. your neurologist needs to evaluate you clinically and if there is an MS suspicion, there are radiological criteria like no. of lesions, their location and size, an diagnostic criteria for MS. there should be a clinical history of previous attacks, CSF examination and MRI findings should substantiate.
5577952 tn?1370323570 As you point out, 99% of us with MS have o-bands unique to our CSF. The absence of o-bands in your CSF does not completely rule out MS, but it makes it far less likely. Quix, a member of our group a while bac, is both a doctor and a person with MS. She wrote a very good explanation of o-bands here: http://www.medhelp.
Avatar n tn I understand a finding of oligoclonal bands in the CSF serves as confirmation in approximately 90% of MS patients (the percentage seems to vary). Does this mean that the bands will not appear in 10% of patients with MS, or does it completely rule out the diagnosis?
736529 tn?1233080422 My interest in spinal cord injuries was kindled by the personal tragedy that I saw on a daily basis in clinical practice. All too often, individuals who are living normal productive and carefree lives one moment are changed instantaneously to living in a wheelchair. Although many of these people live active productive lives, it seemed that much good could be brought about by early, effective treatment of this condition.
Avatar f tn Get my CSF results next wednesday and just want to what the MD is talking about.
Avatar n tn there r articles on spontanious CSF leaks...if she has ne disks that r bulging with a node on them ...that could be a cause. Has ur mother had an MRI of her thoracic,and lumbar spine? Also have her BP checked if not already. http://www.ncbi.nlm.nih.gov/pubmed/18503841 http://www.dizziness-and-balance.com/disorders/central/csf-leak.html Both links have info that u may find helpful. Good luck...please post an update!!
Avatar f tn hi, All i was told is its 5mm and a mri was done.
1391695 tn?1298139789 Severe sickle cell crisis resulting in death has been associated with filgrastim in patients with sickle cell disease. Risks and benefits of filgrastim use in patients with sickle cell disease must be carefully considered. Since filgrastim single-dose vials and prefilled syringes do not contain preservatives, the vial or prefilled syringe should only be used once and any unused portion should be discarded. References 1.
443922 tn?1374157016 Hi Everyone, I was due for 3rd of 48 shots last nite, but was call by by GI (Fri) yesterday and told not to take my shot because my WBC was low. Also advised to continue Riba and wait for nurse to get "hormone??" approval from my ins. co. I have had HCV for about 20 years, dx in 2003, but due to lack of ins. could not get tx till now. Bx will be at the end of April. VL was 2,250.000, I am a 1a, and have had little to no testing prior to 11/07.
Avatar f tn Im 35 weeks and i havent had any practice contractions/ pains is this normal ??? Everything i read says you should start having them at 34 weeks + ....
493068 tn?1224765315 my stats seem to go up and down so I only have to take it now every 2 wks. It is unknown whether filgrastim (Neupogen) increases or decreasses an individual's risk of developing cancer. Based on limited long-term data from healthy people ( if a person is healthy why would they need neupogen in the first place ) who have received filgrastim, no long-term risks have been found so far. good luck to you....hope this helped!
Avatar f tn To distinguish between oligoclonal bands in the CSF due to a peripheral gammopathy and oligoclonal bands due to local production in the CNS, serum and CSF should be tested simultaneously. Oligoclonal bands can however be observed in a variety of other diseases, e.g., subacute sclerosing panencephalitis, inflammatory polyneuropathy, CNS lupus, and brain tumors and infarctions.
198419 tn?1360242356 CSF in differential diagnosis of MS: http://jnnp.bmj.com/content/71/suppl_2/ii9.full.pdf+html This is a good one too - like the 1st link it includes CSF in differential dx. For those who are interested in knowing what the CSF of differential dx's looks like, i.e., ADEM Whipples disease Neurosarcoidosis Behcet's disease Sjogrens Cerebral vasculitus SLE Non-disseminated demyelination Transvers myelitis Foix-Alajouanine HIV Infectious disease (i.e.